Zimbabwe. The Medicines Control Authority has cancelled the registration of all chlormezanone-containing products in the light of international actions taken on the basis of a safety evaluation of chlormezanone. This drug has been associated with an unacceptable incidence of Stevens-Johnson syndrome.

[See also Pharmaceuticals Newsletters Nos. 3&4, March & April 1998, 1&2, January & February 1997, 11&12, November & December 1997 and DRS Alert No. 53, 18 October 1996]

Reference: Drug Information Bulletin Vol.2, No.1, March 1998.